Literature DB >> 498067

Response of 9L tumor cells in vitro to spirohydantoin mustard.

D F Deen, T Hoshino, M E Williams, K Nomura, P M Bartle.   

Abstract

The effects of spirohydantoin mustard (SHM), a potential antitumor agent for central nervous system tumors, in the in vitro 9L rat brain tumor model were studied. In cell culture medium at 37 degrees, the drug was totally detoxified within 30 min. Dose-response curves for exponentially growing and plateau-phase cells were similar and indicated that a small fraction of cells were resistant to SHM. When exponentially growing cells were treated with SHM (5 microgram/ml for 1 hr), recovery from potentially lethal damage occurred within 28 hr. When cells were perturbed by SHM, the S, G2, and M phases were prolonged, there was a G2 block, some cells entered mitosis, but few divided, and cells tended to accumulate in mid-S, then moved synchronously to G2-M. The rate at which cells moved was concentration dependent and was much slower at high concentrations. The ability of SHM to both synchronize cells and block DNA synthesis may be useful in multiagent therapy regimens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498067

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells.

Authors:  S D Henderson; B F Kimler; M L Barnes
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 2.  Spiromustine: a new agent entering clinical trials.

Authors:  D D Shoemaker; P J O'Dwyer; S Marsoni; J Plowman; J P Davignon; R D Davis
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.